Bioline Rx reported $13.68M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Arca Biopharma USD 31.78M 8.81M Sep/2026
Bio Path USD 9.15M 468K Mar/2026
Bioline Rx USD 13.68M 55K Jun/2026
Capricor Therapeutics USD 29.9M 3.07M Sep/2026